Promoting Quality in Drug Manufacturing

FDA is re-engineering the CMC review process for innovator and generic drugs and backing risk-based ICH quality standards.

Related Content:

Process and ScalingManufacturingQuality SystemsRegulatory Oversight and ComplianceDrug DevelopmentPharmaceutical Technology-09-02-2004

Drug Digest: Patient Preference Drives Solid Dosage Trends

Ask the Expert: Quality Control Units

Behind the Headlines, Episode 17: Bespoke CRISPR Therapy, Executive Order Fallout, and More